BofA Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $68

Futu NewsNov 14 23:31 · Ratings

Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $65

Futu NewsNov 14 21:35 · Ratings

LifeSci Capital Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $84

Futu NewsNov 14 21:35 · Ratings

Tarsus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow JonesNov 14 21:26 · Ratings

Tarsus Pharmaceuticals Analyst Ratings

BenzingaNov 14 21:16 · Ratings

Express News | Tarsus Pharmaceuticals Inc : BofA Global Research Raises Price Objective to $68 From $62

BreakingsNov 14 19:18